Abstract
Endophytic actinomycetes from medicinal plants produce a wide diversity of secondary metabolites (SM). However, to date, the knowledge about endophytes from Brazil remains scarce. Thus, we analyzed the antimicrobial potential of 10 actinomycetes isolated from the medicinal plant Vochysia divergens located in the Pantanal sul-mato-grossense, an unexplored wetland in Brazil. Strainswere classified as belonging to the Aeromicrobium, Actinomadura, Microbacterium, Microbispora, Micrococcus, Sphaerisporangium, Streptomyces, and Williamsia genera, through morphological and 16S rRNA phylogenetic analyzes. A susceptibility analysis demonstrated that the strains were largely resistant to the antibiotics oxacillin and nalidixic acid. Additionally, different culture media (SG and R5A), and temperatures (28 and 36°C) were evaluated to select the best culture conditions to produce the active SM. All conditions were analyzed for active metabolites, and the best antibacterial activity was observed from metabolites produced with SG medium at 36°C. The LGMB491 (close related to Aeromicrobium ponti) extract showed the highest activity against methicillin-resistant Staphylococcus aureus (MRSA), with a MIC of 0.04 mg/mL, and it was selected for SM identification. Strain LGMB491 produced 1-acetyl-β-carboline (1), indole-3-carbaldehyde (2), 3-(hydroxyacetyl)-indole (4), brevianamide F (5), and cyclo-(L-Pro-L-Phe) (6) as major compounds with antibacterial activity. In this study, we add to the knowledge about the endophytic community from the medicinal plant V. divergens and report the isolation of rare actinomycetes that produce highly active metabolites.
| Original language | English |
|---|---|
| Article number | 1642 |
| Journal | Frontiers in Microbiology |
| Volume | 8 |
| Issue number | SEP |
| DOIs | |
| State | Published - Sep 6 2017 |
Bibliographical note
Publisher Copyright:© 2017 Gos, Savi, Shaaban, Thorson, Aluizio, Possiede, Rohr and Glienke.
Funding
This work was supported by Fundação Araucária de Apoio e Desenvolvimento Científico e Tecnológico do Paraná—Brazil, grant 441/2012—23510 to CG, CNPq-Brazil grant 486016/2011-0 to CG, and CAPES-Brazil—grant to DS. It was also supported in part by the University of Kentucky College of Pharmacy, the University of Kentucky Markey Cancer Center and the National Center for Advancing Translational Sciences (UL1TR001998), and by NIH grants CA 091091 and GM 105977 as well as an Endowed University Professorship in Pharmacy to JR.
| Funders | Funder number |
|---|---|
| CAPES Foundation, Ministry of Education of Brazil | |
| CNPq-Brazil | 486016/2011-0 |
| University of Kentucky | |
| National Institutes of Health (NIH) | GM 105977, CA 091091 |
| National Center for Advancing Translational Sciences (NCATS) | UL1TR001998 |
| University of Kentucky Markey Cancer Center | |
| Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico | 441/2012—23510 |
Keywords
- Actinomycetes
- Endophytes
- MRSA
- Pantanal
- Secondary metabolites
- Vochysia divergens
ASJC Scopus subject areas
- Microbiology
- Microbiology (medical)
Fingerprint
Dive into the research topics of 'Antibacterial activity of endophytic actinomycetes isolated from the medicinal plant Vochysia divergens (Pantanal, Brazil)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver